CINECA IRIS Institutional Research Information System
IRIS è la soluzione IT che facilita la raccolta e la gestione dei dati relativi alle attività e ai prodotti della ricerca. Fornisce a ricercatori, amministratori e valutatori gli strumenti per monitorare i risultati della ricerca, aumentarne la visibilità e allocare in modo efficace le risorse disponibili.
EnglishThis article describes the synthesis and the biological evaluation of two sets of benzothiazole derivatives bearing at C-2 an arylamide (1a–e, 2a–e) or an arylurea (3a–d, 4a–d) moiety. Five compounds (3d and 4a–d) were selected and screened by the National Cancer Institute for the in vitro primary anticancer assay against a panel of 60 human tumor cell lines. Compounds 4a and 4c showed interesting anticancer activities, more marked for compound 4c. All compounds were also submitted to a preliminary in vitro assay as potential inhibitors of the ubiquitin-activating enzyme (E1), but they lacked significant activity.
| Titolo: | Synthesis of benzothiazole derivatives and their biological evaluation as anticancer agents |
| Autori: | |
| Data di pubblicazione: | 2012 |
| Rivista: | |
| Abstract: | This article describes the synthesis and the biological evaluation of two sets of benzothiazole derivatives bearing at C-2 an arylamide (1a–e, 2a–e) or an arylurea (3a–d, 4a–d) moiety. Five compounds (3d and 4a–d) were selected and screened by the National Cancer Institute for the in vitro primary anticancer assay against a panel of 60 human tumor cell lines. Compounds 4a and 4c showed interesting anticancer activities, more marked for compound 4c. All compounds were also submitted to a preliminary in vitro assay as potential inhibitors of the ubiquitin-activating enzyme (E1), but they lacked significant activity. |
| Handle: | http://hdl.handle.net/11570/1917004 |
| Appare nelle tipologie: | 14.a.1 Articolo su rivista |
File in questo prodotto:
http://hdl.handle.net/11570/1917004
Copyright © 2021